{"organizations": [], "uuid": "978b5d3816d52e9986426d68441b4658177e193d", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-abbott-and-surmodics-announce-agre/brief-abbott-and-surmodics-announce-agreement-for-next-generation-drug-coated-balloon-idUSFWN1QH125", "country": "US", "domain_rank": 408, "title": "BRIEF-Abbott And Surmodics Announce Agreement For Next-Generation Drug-Coated Balloon", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-27T16:03:00.000+02:00", "replies_count": 0, "uuid": "978b5d3816d52e9986426d68441b4658177e193d"}, "author": "", "url": "https://www.reuters.com/article/brief-abbott-and-surmodics-announce-agre/brief-abbott-and-surmodics-announce-agreement-for-next-generation-drug-coated-balloon-idUSFWN1QH125", "ord_in_thread": 0, "title": "BRIEF-Abbott And Surmodics Announce Agreement For Next-Generation Drug-Coated Balloon", "locations": [], "entities": {"persons": [{"name": "dru", "sentiment": "negative"}, {"name": "abbott", "sentiment": "none"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 04 PM / Updated 8 minutes ago BRIEF-Abbott And Surmodics Announce Agreement For Next-Generation Drug-Coated Balloon Reuters Staff Feb 27 (Reuters) - Abbott Laboratories: * ABBOTT AND SURMODICS ANNOUNCE AGREEMENT FOR NEXT-GENERATION DRUG-COATED BALLOON * SURMODICS INC - ‍PURSUANT TO TERMS OF AGREEMENT, SURMODICS WILL RECEIVE A $25 MILLION UPFRONT PAYMENT​ * SURMODICS INC - ‍PURSUANT TO TERMS OF AGREEMENT, CO MAY EARN AN ADDITIONAL $67 MILLION FOR VARIOUS PRODUCT DEVELOPMENT MILESTONES​ * SURMODICS - ENTERED INTO AGREEMENT WHEREBY ABBOTT WILL HAVE EXCLUSIVE WORLDWIDE COMMERCIALIZATION RIGHTS FOR CO‘S SURVEI DRUG-COATED BALLOON * SURMODICS INC - WILL BE RESPONSIBLE FOR MANUFACTURE AND SUPPLY OF CLINICAL AND COMMERCIAL QUANTITIES OF PRODUCT​ * SURMODICS INC - ‍ABBOTT ALSO RECEIVED OPTIONS TO NEGOTIATE AGREEMENTS FOR CO‘S BELOW-THE-KNEE AND AV FISTULA DRUG-COATED BALLOON PRODUCTS​ Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-02-27T16:03:00.000+02:00", "crawled": "2018-02-27T16:13:41.016+02:00", "highlightTitle": ""}